In 2019, our son Logan was diagnosed with a very rare sarcoma cancer. His frontline therapy consisted of a chemotherapies that are the most intense and aggressive treatments. We discovered early on that treatment options were very limited and hadn’t been updated since the 70’s. It was evident that we needed to do more within the pediatric oncology world in order to change the limited options that were in place. Our mission is to find curative and better therapeutic options for pediatric sarcoma